The impact of Covid-19 on healthcare shows that 70–80 percent people responded positively towards at-home-care settings across consultations, diagnostics, day-care services, and in-patient care.
Read More
The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the special economic zone (SEZ), Ahmedabad.
Read More
The hospitals that were already financially fragile over the past few years have been stressed with the unplanned investments for COVID-19 preparedness and response; and have seen their revenues topple due to a 60-80 per cent decline in patient footfalls, leading to estimated operational losses of Rs 4500 crore per month
Read More
With excessive light shed upon the fact that people with a low immune system, or senior citizens are more likely prone to getting infected by Covid-19, it can be said that they are literally living dangerously.
Read More
The Covid-19 vaccine candidate Covaxin, developed by ICMR and Bharat Biotech, is currently in Phase I/II human trials and is being tested at 12 institutes across India.
Read More
Gilead's offer will be funded with $15 billion in cash on hand, and through $6 billion in newly issued debt, according to the drugmaker.
Read More
The Covid-19 vaccine search has led to a hiccup in the process where a UK participant reportedly developed reaction during the trials. Serum Institute of India responds saying it cannot comment on UK trials
Read More
Germany's Leukocare, which is working on a vaccine similar to AstraZeneca's but at an earlier stage, agreed that safety issues are likely to crop up in large trials.
Read More
